Salzburg Country Hospitals–Paracelsus Medical University Hospital Salzburg (SALK) has selected the RayStation® treatment planning system, which it will use for photon therapy. The agreement covers three RayStation Planning licenses and five RayStation Doctor licenses, and functionality will include RayStation’s multi-criteria optimization.
The Department of Radiotherapy and Radio-Oncology at the University Hospital Salzburg is an advanced clinic with a history of technical development, including its own treatment planning system and oncology information system and other innovations to benefit patients. RayStation will be used to plan for patients to be treated on Elekta linacs.
Professor Felix Sedlmayer, head of the department, says: “We chose RayStation following a thorough evaluation of competing treatment planning systems. We are a clinic that aims to be at the forefront of medical technology, and RayStation will help us achieve our goals. It is a highly innovative system that supports the most advanced treatment techniques and will provide us with new treatment possibilities.”
Johan Löf, CEO of RaySearch, says: “I am delighted to support the future needs of SALK, a leading center that values innovation and prioritizes technology as a key factor in improving patient care. We have designed RayStation to meet the needs of clinics such as SALK, which work with advanced techniques. RayStation supports cutting-edge approaches and provides the best possible user experience for clinicians.”
SALK (Gemeinnützige Salzburger Landeskliniken Betriebsgesellschaft mbH) combines healthcare, research and teaching at its two sites in Salzburg, together building the Paracelsus Medical University Hospital. With approximately 5,500 employees, it is the largest employer in the region. SALK has 1,725 beds and over 80,000 patients per year are admitted to the two locations. The Department of Radiotherapy and Radio-Oncology serves an area that extends into neighboring Bavaria, Germany, as well as into Styria and Upper Austria, with over 800,000 inhabitants.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®*, which comprises a new product area for RaySearch, and which will be launched in December 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00